Here's what we do

Generative Design of GLP-1 Analogs

Researchers used AI to design new drug candidates for treating brain and metabolic disorders. The system generates and tests molecules digitally to find those with the best chances of success. This approach speeds up drug discovery and helps identify promising treatments more efficiently.

  • Company: Undisclosed
  • Industry: Biotechnology